Related Experiment Video

Updated: Aug 17, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression

L Rickardson1, M Fryknäs, S Dhar

  • 1Department of Medical Sciences, Division of Clinical Pharmacology, Uppsala University Hospital, Sweden.

British Journal of Cancer
|July 14, 2005
PubMed

Insights

Understanding cancer drug resistance is key. This study links gene expression in resistant cell lines to drug sensitivity, identifying key genes and pathways for developing new cancer treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Acquired drug resistance significantly hinders effective cancer chemotherapy.
  • Identifying genes associated with chemosensitivity and resistance is crucial for improving treatment outcomes.

Purpose of the Study:

  • To explore genes involved in cancer drug sensitivity and resistance.
  • To correlate gene expression profiles with the activity of various anticancer agents.
  • To identify molecular pathways implicated in drug resistance.

Main Methods:

  • Utilized cDNA microarray technology to profile mRNA expression of 7400 genes in 10 human tumor cell lines (parental and drug-resistant).
  • Assessed the activity of 66 anticancer agents across these cell lines.
  • Calculated and ranked correlations between drug activity and gene expression, employing hierarchical clustering and PathwayAssist software.

Main Results:

  • Identified proapoptotic and antiapoptotic genes (e.g., STAT1, MAPK1, FAK) associated with drug resistance.
  • Found genes related to cell cycle control and proliferation (e.g., CDC25A, STAT5A) linked to general drug sensitivity.
  • Clustered drugs based on gene correlations, revealing drugs with similar mechanisms of action.

Conclusions:

  • Combined drug activity and gene expression data from a resistant cell line panel offer insights into anticancer drug resistance.
  • This approach can serve as a valuable tool in the development of novel cancer therapeutics.
  • Reveals specific gene categories influencing sensitivity and resistance, guiding future drug discovery efforts.

More Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...